Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 38Myelodysplastic Syndromes 9Leukemia 6Leukemia, Monocytic, Acute 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Myeloproliferative Disorders 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myelomonocytic, Acute 2Burkitt Lymphoma 2Thrombocythemia, Essential 1Recurrence 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Lymphoid 1Leukemia, Erythroblastic, Acute 1Leukemia, Biphenotypic, Acute 1Hodgkin Disease 1Congenital Abnormalities 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Cyclophosphamide 27fludarabine phosphate 26Mycophenolic Acid 22Tacrolimus 17Busulfan 17Antilymphocyte Serum 17Peripheral Blood Stem Cell Transplantation 16Whole-Body Irradiation 15Methotrexate 15Melphalan 15Filgrastim 15Cyclosporine 15thymoglobulin 10fludarabine 10Methylprednisolone 9Thiotepa 8Radiotherapy 8Stem Cell Transplantation 7Granulocyte Colony-Stimulating Factor 7Cytarabine 7Cord Blood Stem Cell Transplantation 7Etoposide 6Clofarabine 6Rituximab 5Sirolimus 4Antibodies 4Alemtuzumab 4Flow Cytometry 3Azacitidine 3merphos 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Leukemia, Myelomonocytic, Juvenile × CPX-351 × Clear all
NCT05656248 2026-02-04

Study of CPX-351 (VYXEOS) in Individuals < 22 Years With Secondary Myeloid Neoplasms

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
25 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡